US Stock MarketDetailed Quotes

GILD Gilead Sciences

Watchlist
  • 104.080
  • -1.880-1.77%
Close Feb 14 16:00 ET
  • 104.500
  • +0.420+0.40%
Post 20:01 ET
129.68BMarket Cap273.89P/E (TTM)

Gilead Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
6.04%28.75B
6.40%7.57B
7.02%7.55B
5.36%6.95B
5.26%6.69B
-0.60%27.12B
-3.72%7.11B
0.11%7.05B
5.42%6.6B
-3.61%6.35B
Operating revenue
6.04%28.75B
6.40%7.57B
7.02%7.55B
5.36%6.95B
5.26%6.69B
-0.60%27.12B
-3.72%7.11B
0.11%7.05B
5.42%6.6B
-3.61%6.35B
Cost of revenue
-3.80%6.25B
-24.35%1.58B
0.58%1.57B
7.07%1.54B
10.78%1.55B
14.87%6.5B
49.71%2.09B
12.19%1.57B
0.00%1.44B
-1.62%1.4B
Gross profit
9.14%22.5B
19.19%5.99B
8.86%5.97B
4.89%5.41B
3.70%5.13B
-4.65%20.62B
-16.17%5.02B
-2.87%5.49B
7.04%5.16B
-4.16%4.95B
Operating expense
1.61%12B
17.61%3.55B
2.02%2.83B
-16.22%2.73B
92.52%5.33B
10.87%11.81B
247.47%3.02B
17.36%2.77B
32.41%3.26B
-44.25%2.77B
Selling and administrative expenses
0.02%6.09B
18.53%1.91B
8.97%1.43B
-25.53%1.38B
4.25%1.38B
7.35%6.09B
-20.40%1.61B
8.41%1.32B
36.26%1.85B
21.79%1.32B
Research and development costs
3.31%5.91B
16.55%1.64B
-4.26%1.4B
-3.98%1.35B
172.98%3.95B
14.89%5.72B
222.22%1.41B
26.81%1.46B
27.68%1.41B
-62.69%1.45B
Operating profit
19.24%10.51B
21.56%2.44B
15.85%3.14B
41.03%2.68B
-108.74%-191M
-19.72%8.81B
-60.82%2.01B
-17.41%2.71B
-19.42%1.9B
965.85%2.19B
Net non-operating interest income expense
-3.50%-977M
52.85%-248M
-47.62%-186M
-3.04%-237M
-10.43%-254M
-0.96%-944M
-132.74%-526M
44.98%-126M
4.96%-230M
3.36%-230M
Non-operating interest income
----
----
-50.94%52M
----
----
----
----
--106M
----
----
Non-operating interest expense
3.50%977M
-1.59%248M
2.59%238M
3.04%237M
10.43%254M
0.96%944M
11.50%252M
1.31%232M
-4.96%230M
-3.36%230M
Other net income (expense)
-777.56%-8.84B
-114.12%-24M
-643.87%-2B
-367.86%-393M
-516.79%-4.04B
76.17%-1.01B
105.93%170M
56.89%-269M
86.32%-84M
-450.42%-655M
Gain on sale of security
----
----
253.57%258M
----
----
----
----
---168M
----
----
Special income (charges)
-633.86%-8.84B
102.77%11M
-2,378.02%-2.26B
83.90%-38M
-758.84%-4.13B
66.93%-1.21B
86.11%-397M
79.69%-91M
28.48%-236M
-5,912.50%-481M
-Less:Other special charges
303.72%4.66B
-103.17%-11M
454.95%505M
-83.90%38M
758.84%4.13B
22.35%1.16B
119.62%347M
-79.69%91M
-28.48%236M
5,912.50%481M
-Write off
8,260.00%4.18B
--0
--1.75B
--0
----
-98.15%50M
--50M
--0
--0
----
Other non- operating income (expenses)
-96.97%6M
-116.59%-35M
60.00%-4M
-333.55%-355M
152.30%91M
134.08%198M
2,210.00%211M
94.32%-10M
153.52%152M
-56.76%-174M
Income before tax
-89.94%690M
31.16%2.17B
-58.76%956M
29.28%2.05B
-445.08%-4.49B
17.97%6.86B
-18.61%1.65B
-4.69%2.32B
5.66%1.59B
955.26%1.3B
Income tax
-83.08%211M
62.45%385M
-303.42%-297M
-20.22%438M
-199.68%-315M
-0.08%1.25B
-40.45%237M
-77.40%146M
49.18%549M
292.68%316M
Net income
-91.45%480M
25.83%1.78B
-42.31%1.25B
55.34%1.61B
-523.35%-4.17B
22.93%5.61B
-13.23%1.42B
21.61%2.17B
-8.46%1.04B
8,108.33%985M
Net income continuous Operations
-91.46%479M
25.92%1.78B
-42.31%1.25B
55.44%1.62B
-523.88%-4.17B
22.91%5.61B
-13.29%1.42B
21.61%2.17B
-8.46%1.04B
8,100.00%984M
Minority interest income
0
0
0
0
0
-100.00%-52M
-71.43%-12M
-166.67%-8M
33.33%-6M
-271.43%-26M
Net income attributable to the parent company
-91.53%480M
24.77%1.78B
-42.52%1.25B
54.45%1.61B
-512.87%-4.17B
23.37%5.67B
-12.87%1.43B
21.86%2.18B
-8.65%1.05B
5,215.79%1.01B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-91.53%480M
24.77%1.78B
-42.52%1.25B
54.45%1.61B
-512.87%-4.17B
23.37%5.67B
-12.87%1.43B
21.86%2.18B
-8.65%1.05B
5,215.79%1.01B
Basic earnings per share
-91.63%0.38
24.35%1.43
-42.86%1
53.57%1.29
-512.35%-3.34
24.04%4.54
-12.21%1.15
22.38%1.75
-7.69%0.84
3,950.00%0.81
Diluted earnings per share
-91.56%0.38
24.56%1.42
-42.20%1
55.42%1.29
-517.50%-3.34
23.63%4.5
-12.31%1.14
21.83%1.73
-8.79%0.83
3,900.00%0.8
Dividend per share
2.67%3.08
2.67%0.77
2.67%0.77
2.67%0.77
2.67%0.77
2.74%3
2.74%0.75
2.74%0.75
2.74%0.75
2.74%0.75
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 6.04%28.75B6.40%7.57B7.02%7.55B5.36%6.95B5.26%6.69B-0.60%27.12B-3.72%7.11B0.11%7.05B5.42%6.6B-3.61%6.35B
Operating revenue 6.04%28.75B6.40%7.57B7.02%7.55B5.36%6.95B5.26%6.69B-0.60%27.12B-3.72%7.11B0.11%7.05B5.42%6.6B-3.61%6.35B
Cost of revenue -3.80%6.25B-24.35%1.58B0.58%1.57B7.07%1.54B10.78%1.55B14.87%6.5B49.71%2.09B12.19%1.57B0.00%1.44B-1.62%1.4B
Gross profit 9.14%22.5B19.19%5.99B8.86%5.97B4.89%5.41B3.70%5.13B-4.65%20.62B-16.17%5.02B-2.87%5.49B7.04%5.16B-4.16%4.95B
Operating expense 1.61%12B17.61%3.55B2.02%2.83B-16.22%2.73B92.52%5.33B10.87%11.81B247.47%3.02B17.36%2.77B32.41%3.26B-44.25%2.77B
Selling and administrative expenses 0.02%6.09B18.53%1.91B8.97%1.43B-25.53%1.38B4.25%1.38B7.35%6.09B-20.40%1.61B8.41%1.32B36.26%1.85B21.79%1.32B
Research and development costs 3.31%5.91B16.55%1.64B-4.26%1.4B-3.98%1.35B172.98%3.95B14.89%5.72B222.22%1.41B26.81%1.46B27.68%1.41B-62.69%1.45B
Operating profit 19.24%10.51B21.56%2.44B15.85%3.14B41.03%2.68B-108.74%-191M-19.72%8.81B-60.82%2.01B-17.41%2.71B-19.42%1.9B965.85%2.19B
Net non-operating interest income expense -3.50%-977M52.85%-248M-47.62%-186M-3.04%-237M-10.43%-254M-0.96%-944M-132.74%-526M44.98%-126M4.96%-230M3.36%-230M
Non-operating interest income ---------50.94%52M------------------106M--------
Non-operating interest expense 3.50%977M-1.59%248M2.59%238M3.04%237M10.43%254M0.96%944M11.50%252M1.31%232M-4.96%230M-3.36%230M
Other net income (expense) -777.56%-8.84B-114.12%-24M-643.87%-2B-367.86%-393M-516.79%-4.04B76.17%-1.01B105.93%170M56.89%-269M86.32%-84M-450.42%-655M
Gain on sale of security --------253.57%258M-------------------168M--------
Special income (charges) -633.86%-8.84B102.77%11M-2,378.02%-2.26B83.90%-38M-758.84%-4.13B66.93%-1.21B86.11%-397M79.69%-91M28.48%-236M-5,912.50%-481M
-Less:Other special charges 303.72%4.66B-103.17%-11M454.95%505M-83.90%38M758.84%4.13B22.35%1.16B119.62%347M-79.69%91M-28.48%236M5,912.50%481M
-Write off 8,260.00%4.18B--0--1.75B--0-----98.15%50M--50M--0--0----
Other non- operating income (expenses) -96.97%6M-116.59%-35M60.00%-4M-333.55%-355M152.30%91M134.08%198M2,210.00%211M94.32%-10M153.52%152M-56.76%-174M
Income before tax -89.94%690M31.16%2.17B-58.76%956M29.28%2.05B-445.08%-4.49B17.97%6.86B-18.61%1.65B-4.69%2.32B5.66%1.59B955.26%1.3B
Income tax -83.08%211M62.45%385M-303.42%-297M-20.22%438M-199.68%-315M-0.08%1.25B-40.45%237M-77.40%146M49.18%549M292.68%316M
Net income -91.45%480M25.83%1.78B-42.31%1.25B55.34%1.61B-523.35%-4.17B22.93%5.61B-13.23%1.42B21.61%2.17B-8.46%1.04B8,108.33%985M
Net income continuous Operations -91.46%479M25.92%1.78B-42.31%1.25B55.44%1.62B-523.88%-4.17B22.91%5.61B-13.29%1.42B21.61%2.17B-8.46%1.04B8,100.00%984M
Minority interest income 00000-100.00%-52M-71.43%-12M-166.67%-8M33.33%-6M-271.43%-26M
Net income attributable to the parent company -91.53%480M24.77%1.78B-42.52%1.25B54.45%1.61B-512.87%-4.17B23.37%5.67B-12.87%1.43B21.86%2.18B-8.65%1.05B5,215.79%1.01B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -91.53%480M24.77%1.78B-42.52%1.25B54.45%1.61B-512.87%-4.17B23.37%5.67B-12.87%1.43B21.86%2.18B-8.65%1.05B5,215.79%1.01B
Basic earnings per share -91.63%0.3824.35%1.43-42.86%153.57%1.29-512.35%-3.3424.04%4.54-12.21%1.1522.38%1.75-7.69%0.843,950.00%0.81
Diluted earnings per share -91.56%0.3824.56%1.42-42.20%155.42%1.29-517.50%-3.3423.63%4.5-12.31%1.1421.83%1.73-8.79%0.833,900.00%0.8
Dividend per share 2.67%3.082.67%0.772.67%0.772.67%0.772.67%0.772.74%32.74%0.752.74%0.752.74%0.752.74%0.75
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%
Bitfarms
BITF
+1.43%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.74%
Mpox (monkeypox)
Mpox (monkeypox)
Intraday-0.92%
CAR-T Therapy
CAR-T Therapy
Intraday-1.13%